Squalamine lactate for injection (MSI-1256F)

Squalamine lactate · Genaera Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Squalamine lactate for injection (MSI-1256F), covering 2007-11-28 to 2007-11-28. Get the full timeline:

Most recent: Clinical Trial Update: A Safety and Efficacy Study of Squalamine Lactate for Injection (MSI-1256F) for "Wet" Age-Related Macular Degeneration [Phase 3]

See pricing